ArticleOncoTargets and therapy2021

GDC-0575, a CHK1 Inhibitor, Impairs the Development of Colitis and Colitis-Associated Cancer by Inhibiting CCR2

Min Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.